Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of memantine on cognitive performance in patients undergoing electroconvulsive therapy
IRCT20170606034348N3Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in confusion, sponsored by Babol University of Medical Sciences. Primary endpoint: Cognitive performance. Started May 2018; status: completed.
02
Drugs
memantine
03
Conditions
confusion
Beyond the preview
Go deeper on IRCT20170606034348N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170606034348N3.